Introduction
Historically the commonest cause of death from liver surgery was intraoperative bleeding. Advances in surgical technique, low CVP anaesthesia, cell salvage, and tis- This case series represents a single surgeon's experience using a commercially available RF probe for hepatic transection during liver resections (TissueLink TM ).
Patients and Methods

RF Probe
The RF instrument (TissueLink) uses RF energy, via a standard electrocautery generator, to produce heat conducted via a metal probe and saline irrigation. This precoagulates tissue without charring, sealing small vascular and biliary structures. The probe can also be used as a dissector, isolating larger structures in preparation for ligation ( fig. 1 ).
Patients
Over a 30-month period, 125 cases were assessed. Eight were considered unresectable and unablatable and were referred for further treatment to an oncologist. Twelve cases were planned for resection but instead underwent open RF-assisted ablation due to findings at laparotomy. 105 (84%) patients underwent liver resection. Of 97 attempted TissueLink resections, 8 were converted to Kelly-clysis, giving a failure rate of 8.25%. The results of 89 consecutive TissueLink resections are reported. The indications for hepatic resection and patients' characteristics are shown in tables 1 and 2 , respectively.
Procedures
Sixty-four (72%) of the resections involved two or more segments of the liver. Included in these procedures are 9 planned two-stage hepatectomies, and 2 re-hepatectomies for recurrent disease. Two of the trisectionectomies required additional wedge resections at the time of surgery, and one procedure required a portal vein resection and reconstruction. In addition to the hepatectomy, 10 cases required additional synchronous procedures. There were 8 synchronous colectomies, 1 adrenalectomy and 1 gastrectomy. All procedures are shown in table 3 . 
Results
Portal Clamping and CVP Twenty-four patients required portal clamping with a mean clamping time of 5.8 min. There was no CVP control intraoperatively for any of the cases ( table 4 ) .
Blood Loss
Fifty-nine (66%) of patients did not require blood products, while 30 were transfused. Nine patients (10%) required only 1 unit, 12 (13.5%) were transfused between 1 and 3 units, and another 9 required 1 3 units of packed red cells ( table 5 ) .
Morbidity and Mortality
The one biliary stricture occurred early in the series during the learning curve with the TissueLink, due to collateral heat damage to the common hepatic duct from the saline runoff. This was avoided in future cases by avoiding any use of the instrument at the hilum, and protecting the structures with cool saline-soaked swabs. Of the bile leaks, one was related to damage at the CHD during portal vein resection, with the other four due to leaks at the raw edge, and thus attributable to the TissueLink technique ( table 6 ). All lesions were completely excised, with a minimum of 5.2 mm clearance from the resection margin.
Discussion
Compared with large series from international highvolume HPB centres, we have achieved similar rates of morbidity and mortality using the TissueLink device for parenchymal division. Transfusion requirements are also comparable, and median blood loss is somewhat reduced [5] [6] [7] [8] . Hence, it may allow for reduced blood loss compared with accepted standards, and as such can be considered a useful tool in liver resection. One drawback is the potential for high temperature saline to flow onto the extrahepatic biliary tree and cause biliary injury. We would recommend that the TissueLink is not used at the porta hepatis, and that cooled soaked swabs are placed over structures to be preserved.
Having demonstrated the safety and efficacy of TissueLink for liver transection, the question arises whether it compares favourably to the current standards. To address this, we are performing an RCT of CUSA versus TissueLink at the Royal London Hospital. We are randomizing 50 patients to each group, and using standardized anaesthetic monitoring, CVP control and transfusion triggers. The indication for resection, underlying liver status, use of preoperative chemotherapy, surface area of resection and volume of the specimen will be included in the study, with the endpoints being blood loss, transfusion requirements, morbidity and mortality. These results will be published in the near future.
In conclusion, TissueLink parenchymal division is safe, does not result in increased morbidity or mortality, and allows the surgeon to obtain adequate margins on the tumour. 
